Company · CIK 1305253
Eiger BioPharmaceuticals, Inc.
| CIK | 1305253 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2014-03-31 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-251497 | 2020-12-18 | 2022-03-25 | 3 | |
| 333-235655 | 2019-12-20 | 2020-08-06 | 3 | |
| 333-212114 | 2016-06-17 | 2019-04-18 | 9 | |
| 333-221972 | 2017-12-08 | 2018-10-23 | 6 | |
| 333-203153 | 2015-03-31 | 2015-03-31 | 1 | |
| 333-197720 | 2014-07-30 | 2014-08-13 | 4 | |
| 333-191688 | 2013-10-11 | 2014-01-30 | 8 |
Filings
36| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-03-25 | 424B5Shelf takedown | 333-251497 | 0001193125-22-085223 |
| 2020-12-31 | EFFECTDeclared effective | 333-251497 | 9999999995-21-000010 |
| 2020-12-18 | S-3Shelf registered | 333-251497 | 0001193125-20-321539 |
| 2020-08-06 | 424B5Shelf takedown | 333-235655 | 0001193125-20-212104 |
| 2019-12-31 | EFFECTDeclared effective | 333-235655 | 9999999995-20-000006 |
| 2019-12-20 | S-3Shelf registered | 333-235655 | 0001193125-19-321040 |
| 2019-04-18 | 424B5Shelf takedown | 333-212114 | 0001193125-19-110948 |
| 2019-04-17 | 424B5Shelf takedown | 333-212114 | 0001193125-19-109081 |
| 2018-10-23 | 424B5Shelf takedown | 333-221972 | 0001193125-18-305424 |
| 2018-10-22 | 424B5Shelf takedown | 333-221972 | 0001193125-18-304289 |
| 2018-05-25 | 424B5Shelf takedown | 333-221972 | 0001193125-18-175409 |
| 2018-05-23 | 424B5Shelf takedown | 333-221972 | 0001193125-18-172191 |
| 2017-12-20 | EFFECTDeclared effective | 333-221972 | 9999999995-17-003272 |
| 2017-12-08 | S-3Shelf registered | 333-221972 | 0001193125-17-365072 |
| 2017-10-30 | 424B5Shelf takedown | 333-212114 | 0001193125-17-325153 |
| 2017-10-26 | 424B5Shelf takedown | 333-212114 | 0001193125-17-321211 |
| 2017-01-17 | 424B5Shelf takedown | 333-212114 | 0001193125-17-011227 |
| 2016-08-19 | 424B5Shelf takedown | 333-212114 | 0001193125-16-685604 |
| 2016-08-17 | 424B5Shelf takedown | 333-212114 | 0001193125-16-684215 |
| 2016-08-04 | EFFECTDeclared effective | 333-212114 | 9999999995-16-005349 |
| 2016-06-17 | S-3Shelf registered | 333-212114 | 0001193125-16-625162 |
| 2016-02-12 | EFFECTDeclared effective | 333-208521 | 9999999995-16-003755 |
| 2015-03-31 | S-3Shelf registered | 333-203153 | 0001193125-15-114428 |
| 2014-08-13 | 424B4Final prospectus | 333-197720 | 0001193125-14-307193 |
| 2014-08-12 | EFFECTDeclared effective | 333-197720 | 9999999995-14-002478 |
| 2014-08-07 | S-1/AAmendment | 333-197720 | 0001193125-14-298967 |
| 2014-07-30 | S-1Registration filed | 333-197720 | 0001193125-14-285873 |
| 2014-01-30 | 424B4Final prospectus | 333-191688 | 0001193125-14-027264 |
| 2014-01-29 | EFFECTDeclared effective | 333-191688 | 9999999995-14-000243 |
| 2014-01-28 | S-1/AAmendment | 333-191688 | 0001193125-14-022471 |
| 2014-01-22 | S-1/AAmendment | 333-191688 | 0001193125-14-016605 |
| 2013-11-08 | S-1/AAmendment | 333-191688 | 0001193125-13-435498 |
| 2013-11-01 | S-1/AAmendment | 333-191688 | 0001193125-13-421465 |
| 2013-10-29 | S-1/AAmendment | 333-191688 | 0001193125-13-414057 |
| 2013-10-11 | S-1Registration filed | 333-191688 | 0001193125-13-396992 |
| 2013-09-06 | DRSDraft made public | 377-00304 | 0000950123-13-007394 |